CGON
CG ONCOLOGY INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
CG ONCOLOGY INC (CGON) has no tracked common-stock 13F position; 3 tracked managers disclosed PUT or CALL positions with a combined reported value of ~$13.38M; the largest disclosed positions are from Ken Griffin, Izzy Englander, Steven Cohen. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · LowThis quarter · Cooling
Option-position filers3
Congress trades0
Price$70.52vs quarter-end-0.75%
Sectors0
This quarter's moves
Largest option positionNew0
Added0
Trimmed / sold2
Ken GriffinNo tracked common-stock position is currently disclosed for this security.
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $10.60M— of portfolio149,2002026 Q2
Value $1.42M— of portfolio20,0002026 Q2
Value $703.4K— of portfolio9,9002026 Q2
Value $653.7K— of portfolio9,2002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $10.60M | — | — |
| Izzy EnglanderCALL | $1.42M | — | — |
| Ken GriffinPUT | $703.4K | — | — |
| Steven CohenCALL | $653.7K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.